- You can view the full Bristol-Myers Squibb Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
A selloff in crude oil and health care stocks led Wall Street into the red on Wednesday.
BMY dropped after the bad news about a recent failed clinical trial of a new drug. But now the signs are there for a bullish reversal.
Acquiring Medivation will strengthen Pfizer's oncology franchise, which has lost ground in recent years to some Big Pharma competitors.